Hypersomnia
1
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Alliance PharmaceuticalsFlumazenil
Jazz PharmaceuticalsSleep study
Clinical Trials (2)
Total enrollment: 55 patients across 2 trials
Flumazenil for the Treatment of Primary Hypersomnia
Start: Sep 2010Est. completion: Jan 201210 patients
Phase 1/2Completed
Disentangling the Role of Depression in Hypersomnia
Start: Aug 2023Est. completion: Jun 202645 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 55 patients
2 companies competing in this space